Location · Colorado
Clinical trials recruiting in Colorado
591 recruiting studies have at least one site in Colorado; 183 accept healthy volunteers. Studies that need a specific condition are included too, so check each listing.
Want the research companies that run paid Phase 1 studies for healthy volunteers? Paid clinical trial companies in Colorado.
591 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 1/Phase 2
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
COUR Pharmaceutical Development Company, Inc.
- Location
- Aurora, CO + 44 other US sites
- Eligibility basics
- Ages 12–35
- RecruitingPhase 2
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
ONL Therapeutics
- Location
- Colorado Springs, CO + 55 other US sites
- Eligibility basics
- Ages 55+
- RecruitingPhase 3
STOP-HAE: A Phase 3 Study of ADX-324 in HAE
ADARx Pharmaceuticals, Inc.
- Location
- Centennial, CO + 14 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Allogene Therapeutics
- Location
- Aurora, CO + 15 other US sites
- Eligibility basics
- Ages 18–74
- RecruitingPhase 3
Efficacy and Safety of Intranasal Cenegermin in Adult Participants With Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)
Dompé Farmaceutici S.p.A
- Location
- Aurora, CO + 13 other US sites
- Eligibility basics
- Ages 50–80
- RecruitingPhase 3
A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.
AstraZeneca
- Location
- Colorado Springs, CO + 7 other US sites
- Eligibility basics
- Ages 18–130
- Recruiting
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
Inari Medical
- Location
- Denver, CO + 32 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN
Novartis Pharmaceuticals
- Location
- Aurora, CO + 4 other US sites
- Eligibility basics
- Ages 2–18
- RecruitingPhase 3
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Takeda
- Location
- Denver, CO + 18 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2/Phase 3
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
GlaxoSmithKline
- Location
- Aurora, CO + 16 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
Bristol-Myers Squibb
- Location
- Wheat Ridge, CO + 26 other US sites
- Eligibility basics
- Ages 12–17
- RecruitingPhase 3
An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
Inhibikase Therapeutics
- Location
- Aurora, CO + 14 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
A Prospective, Randomized, Single-blind, Controlled, Multi-center Study to Assess the Safety and Performance of MagnetOsTM Compared to Autogenous Bone Graft in Patients Undergoing Hindfoot or Ankle Fusions.
Kuros Biosurgery AG
- Location
- Vail, CO + 6 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2/Phase 3
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
Merck Sharp & Dohme LLC
- Location
- Aurora, CO + 19 other US sites
- Eligibility basics
- Ages 1 mo–17
- RecruitingPhase 2/Phase 3
A Clinical Study Evaluating Licaminlimab for Dry Eye Disease
Oculis
- Location
- Colorado Springs, CO + 11 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
Apollo Therapeutics Ltd
- Location
- Wheat Ridge, CO + 24 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 3
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
Harmony Biosciences Management, Inc.
- Location
- Boulder, CO + 26 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
R1 Therapeutics
- Location
- Denver, CO + 23 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH
Madrigal Pharmaceuticals, Inc.
- Location
- Aurora, CO + 11 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study of Depemokimab in Participants of 6 to 11 Years of Age
GlaxoSmithKline
- Location
- Colorado Springs, CO + 2 other US sites
- Eligibility basics
- Ages 6–11
- RecruitingPhase 3
A Study of Pitolisant in Patients With Prader-Willi Syndrome
Harmony Biosciences Management, Inc.
- Location
- Aurora, CO + 18 other US sites
- Eligibility basics
- Ages 6+
- RecruitingPhase 2
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Immunovant Sciences GmbH
- Location
- Englewood, CO + 54 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)
Relay Therapeutics, Inc.
- Location
- Aurora, CO + 21 other US sites
- Eligibility basics
- Ages 2+
- RecruitingPhase 2
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Immunovant Sciences GmbH
- Location
- Aurora, CO + 32 other US sites
- Eligibility basics
- Ages 18–75